These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23146021)
1. Han ethnicity-specific type 2 diabetic treatment from traditional Chinese medicine? Chen KC; Chang SS; Tsai FJ; Chen CY J Biomol Struct Dyn; 2013; 31(11):1219-35. PubMed ID: 23146021 [TBL] [Abstract][Full Text] [Related]
2. In silico investigation of potential SRC kinase ligands from traditional Chinese medicine. Tou WI; Chen CY PLoS One; 2012; 7(3):e33728. PubMed ID: 22470466 [TBL] [Abstract][Full Text] [Related]
3. Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine. Chen KC; Jian YR; Sun MF; Chang TT; Lee CC; Chen CY J Biomol Struct Dyn; 2013; 31(11):1207-18. PubMed ID: 23075283 [TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884 [TBL] [Abstract][Full Text] [Related]
5. Traditional Chinese medicine application in HIV: an in silico study. Huang HJ; Jian YR; Chen CY J Biomol Struct Dyn; 2014; 32(1):1-12. PubMed ID: 23252879 [TBL] [Abstract][Full Text] [Related]
6. Uroporphyrinogen decarboxylase as a potential target for specific components of traditional Chinese medicine: a virtual screening and molecular dynamics study. Tsou YA; Chen KC; Lin HC; Chang SS; Chen CY PLoS One; 2012; 7(11):e50087. PubMed ID: 23209648 [TBL] [Abstract][Full Text] [Related]
7. Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. Chen KC; Chang SS; Huang HJ; Lin TL; Wu YJ; Chen CY J Biomol Struct Dyn; 2012; 30(6):662-83. PubMed ID: 22731403 [TBL] [Abstract][Full Text] [Related]
8. Identification of zinc ligands of the insulin-degrading enzyme. Perlman RK; Rosner MR J Biol Chem; 1994 Dec; 269(52):33140-5. PubMed ID: 7806544 [TBL] [Abstract][Full Text] [Related]
9. Machine Learning and Molecular Dynamics Based Insights into Mode of Actions of Insulin Degrading Enzyme Modulators. Jamal S; Goyal S; Shanker A; Grover A Comb Chem High Throughput Screen; 2017; 20(4):279-291. PubMed ID: 28137222 [TBL] [Abstract][Full Text] [Related]
10. An in silico insight into novel therapeutic interaction of LTNF peptide-LT10 and design of structure based peptidomimetics for putative anti-diabetic activity. Chavan SG; Deobagkar DD PLoS One; 2015; 10(3):e0121860. PubMed ID: 25816209 [TBL] [Abstract][Full Text] [Related]
11. Exploring the Structural Rearrangements of the Human Insulin-Degrading Enzyme through Molecular Dynamics Simulations. Ghoula M; Janel N; Camproux AC; Moroy G Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163673 [TBL] [Abstract][Full Text] [Related]
12. Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo. Durham TB; Toth JL; Klimkowski VJ; Cao JX; Siesky AM; Alexander-Chacko J; Wu GY; Dixon JT; McGee JE; Wang Y; Guo SY; Cavitt RN; Schindler J; Thibodeaux SJ; Calvert NA; Coghlan MJ; Sindelar DK; Christe M; Kiselyov VV; Michael MD; Sloop KW J Biol Chem; 2015 Aug; 290(33):20044-59. PubMed ID: 26085101 [TBL] [Abstract][Full Text] [Related]
13. In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. Chen KC; Lee WY; Chen HY; Chen CY Biomed Res Int; 2014; 2014():139492. PubMed ID: 25045657 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the inhibitors of histone-lysine N-methyltransferase SETD2 for acute lymphoblastic leukaemia from traditional Chinese medicine. Chang YL; Chen HY; Chen KB; Chen KC; Chang KL; Chang PC; Chang TT; Chen YC SAR QSAR Environ Res; 2016 Jul; 27(7):589-608. PubMed ID: 27218135 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2 Musoev A; Numonov S; You Z; Gao H Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858 [TBL] [Abstract][Full Text] [Related]
16. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer. Chen KC; Sun MF; Chen HY; Lee CC; Chen CY Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636 [TBL] [Abstract][Full Text] [Related]
17. Elucidation of interactions of Alzheimer amyloid beta peptides (Abeta40 and Abeta42) with insulin degrading enzyme: a molecular dynamics study. Bora RP; Prabhakar R Biochemistry; 2010 May; 49(18):3947-56. PubMed ID: 20380468 [TBL] [Abstract][Full Text] [Related]